CLDND1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-59441
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to CLDND1(claudin domain containing 1) The peptide sequence was selected from the middle region of CLDND1.
Peptide sequence TLTEQFMEKFVDPGNHNSGIDLLRTYLWRCQFLLPFVSLGLMCFGALIGL. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for CLDND1 Antibody
Western Blot: CLDND1 Antibody [NBP1-59441]
Western Blot: CLDND1 Antibody [NBP1-59441] - Human Muscle lysate, concentration 0.2-1 ug/ml.Applications for CLDND1 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CLDND1
Alternate Names
C3orf4, chromosome 3 open reading frame 4, claudin domain containing 1, claudin domain containing 1 protein, claudin domain-containing protein 1, GENX-3745, Membrane protein GENX-3745, MGC111162, MGC3316, MGC9861
Gene Symbol
CLDND1
UniProt
Additional CLDND1 Products
Product Documents for CLDND1 Antibody
Product Specific Notices for CLDND1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...